Document Detail


Dissecting the immune cell mayhem that drives lupus pathogenesis.
MedLine Citation:
PMID:  21389262     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The autoimmune disease systemic lupus erythematosus (SLE) results from an inability of the immune system to discriminate between certain self-antigens and foreign ones. The most common treatment of SLE involves the use of immunosuppressive drugs to reduce inflammation, but these therapies have serious side effects. Three recent papers in Science Translational Medicine redirect focus on neutrophils, platelets, and interferon-α in the pathogenesis of SLE and reinforce the notion that researchers should seek to discover and devise combination therapies that target these processes.
Authors:
Joseph E Craft
Publication Detail:
Type:  Comment; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Science translational medicine     Volume:  3     ISSN:  1946-6242     ISO Abbreviation:  Sci Transl Med     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-10     Completed Date:  2011-07-06     Revised Date:  2012-03-16    
Medline Journal Info:
Nlm Unique ID:  101505086     Medline TA:  Sci Transl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  73ps9     Citation Subset:  IM    
Affiliation:
Section of Rheumatology, Department of Internal Medicine, and Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA. joseph.craft@yale.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Autoantibodies / biosynthesis
Blood Platelets / immunology
Humans
Interferon-alpha / biosynthesis
Lupus Erythematosus, Systemic / blood,  etiology*,  immunology*,  therapy
Models, Immunological
Neutrophils / immunology
Platelet Activation
Grant Support
ID/Acronym/Agency:
5 R01 AI075157/AI/NIAID NIH HHS; P30 AR053495/AR/NIAMS NIH HHS; R01 AI075157-05/AI/NIAID NIH HHS; R01 AR040072-23/AR/NIAMS NIH HHS; R01 AR40072/AR/NIAMS NIH HHS; R01 AR44076/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/Autoantibodies; 0/Interferon-alpha
Comments/Corrections
Comment On:
Sci Transl Med. 2011 Mar 9;3(73):73ra20   [PMID:  21389264 ]
Sci Transl Med. 2010 Sep 1;2(47):47ra63   [PMID:  20811042 ]
Sci Transl Med. 2011 Mar 9;3(73):73ra19   [PMID:  21389263 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dodging drug-resistant cancer with diamonds.
Next Document:  Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemi...